The End Brain Cancer Initiative Partners with Exvade Bioscience to Raise Awareness of Groundbreaking Brain Cancer Study
The End Brain Cancer Initiative is promoting awareness and pre-qualifying patients for Exvade Bioscience's Phase 1 Trial (NCT04547777). REDMOND, OR, UNITED STATES, October 30, 2025 /EINPresswire.com/ -- The End Brain Cancer Initiative (EBCI) …